Monocyte and Macrophage Assessment and Histiocytic Disorders

Monocytes circulate in blood and give rise to tissue macrophages and dendritic cells - together the mononuclear phagocyte system. Their assessment spans the blood monocyte count and the recognition of histiocytic disorders, a heterogeneous group of conditions in which macrophages, dendritic cells, or their precursors proliferate or behave abnormally.

Definition

Monocytes are circulating mononuclear phagocytes that mature into tissue macrophages and dendritic cells; histiocytic disorders are conditions characterised by abnormal accumulation or activation of cells of the macrophage-dendritic cell lineages.

Scope

This topic covers the assessment of monocytes and macrophages and the main histiocytic disorders, including Langerhans cell histiocytosis and hemophagocytic lymphohistiocytosis, framed by the revised classification of histiocytoses. It describes how these cells and disorders are recognised and categorised. It is a reference overview and does not provide diagnostic criteria for application to, or management of, any individual.

Core questions

• What are monocytes and how do they relate to tissue macrophages and dendritic cells?
• How are histiocytic disorders classified into major groups?
• What distinguishes Langerhans cell histiocytosis from hemophagocytic lymphohistiocytosis?
• How is monocyte and macrophage assessment positioned within white-cell evaluation?

Key concepts

• Mononuclear phagocyte system
• Monocyte count and morphology
• Macrophage and dendritic-cell differentiation
• Histiocytic disorders
• Langerhans cell histiocytosis
• Hemophagocytic lymphohistiocytosis
• Macrophage activation syndrome
• Revised histiocytosis classification

Mechanisms

Monocytes arise in the marrow and circulate before entering tissues, where they differentiate into macrophages and dendritic cells that phagocytose pathogens and debris, present antigen, and regulate inflammation. Histiocytic disorders reflect derangements of these lineages: the revised classification groups them into Langerhans-related, cutaneous and mucocutaneous, malignant histiocytoses, Rosai-Dorfman disease, and the hemophagocytic lymphohistiocytosis / macrophage activation syndrome group (Emile 2016). Langerhans cell histiocytosis is now understood as a neoplastic disorder driven by activating mutations in the MAPK pathway (notably BRAF V600E) in myeloid dendritic-cell precursors (Allen 2018). Hemophagocytic lymphohistiocytosis, in contrast, is a hyperinflammatory syndrome of excessive, poorly controlled immune activation in which macrophages engulf blood cells; it may be familial or acquired and is defined by a set of clinical and laboratory criteria (Henter 2007; Jordan 2011).

Clinical relevance

Monocyte and macrophage assessment and the recognition of histiocytic disorders inform how a wide range of inflammatory, infiltrative, and hyperinflammatory presentations are investigated at the laboratory and pathologic level. This entry describes the cell types and disease categories for reference; it does not provide diagnostic criteria or treatment guidance for any individual.

Epidemiology

Histiocytic disorders are individually uncommon; Langerhans cell histiocytosis is the most frequent and occurs across the age range but is most often recognised in children, while hemophagocytic lymphohistiocytosis includes both familial forms presenting in early childhood and acquired forms across all ages (Allen 2018; Jordan 2011).

Evidence & guidelines

The framework for these disorders is the revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages (Emile 2016). Authoritative reviews describe the biology and recognition of Langerhans cell histiocytosis (Allen 2018), and consensus criteria and expert syntheses define hemophagocytic lymphohistiocytosis (Henter 2007; Jordan 2011).

Debates

Is Langerhans cell histiocytosis inflammatory or neoplastic?

Long debated as a reactive or inflammatory process, Langerhans cell histiocytosis is now widely regarded as a clonal myeloid neoplasm driven by MAPK-pathway activation, reframing how it is understood and classified.

Seminal works

• emile-2016
• allen-2018
• henter-2007

Frequently asked questions

How are monocytes related to macrophages?

Monocytes are the circulating form; after entering tissues they differentiate into macrophages (and dendritic cells), so the two are stages of the same mononuclear phagocyte system.

What are histiocytic disorders?

They are a heterogeneous group of conditions in which cells of the macrophage-dendritic cell lineages accumulate or become abnormally activated, ranging from Langerhans cell histiocytosis to hemophagocytic lymphohistiocytosis.